Drawing for NOOMATO

USPTO serial 79244022

NOOMATO

Reviewed by CopyMark Law Group

Reg. 5870501Status 709
Filing date
Status date
Registration date
Oct 1, 2019
Examiner
LAVACHE, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOOMATO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alex Patel

ALEX PATEL PATEL & ALMEIDA, P.C.16830 VENTURA BLVDSUITE 360ENCINO, CA 91436

Goods and services

ClassDescriptionStatusFirst use
001Chemical supplements for use in the manufacture of vitamins; vitamins for the manufacture of food supplements; antioxidants for the manufacture of food supplements; proteins for the manufacture of food supplements; enzymes for use in the manufacture of nutraceuticals; carbohydrates for use in the manufacture of nutraceuticals; chemical preparations for use in the pharmaceutical industry; chemical preserving agents for the pharmaceutical industry; vitamins for the food industry; proteins for the food industry; enzyme preparations for the food industry; probiotic bacterial cultures for the food industry; chemical preparations for use in the manufacture of pharmaceutical products; emollients for use in the manufacture of pharmaceutical products; antioxidants for the manufacture of pharmaceutical products; active chemical ingredients for manufacture of pharmaceutical products; biological preparations other than for medical use, namely, biological preparations for use in industry and scienceSECTION 71 - CANCELLED—
005Veterinary preparations and substances for the treatment of gastrointestinal diseases, intestinal bacteria; biological preparations for veterinary use for the treatment of gastrointestinal disease, infectious diseases; dietetic substances for veterinary use, namely, dietary supplements for veterinary use; dietary supplements for persons with special diets; food supplements; vitamin supplements; nutritional supplements; anti-oxidant food supplements; probiotic supplements; nutritional and food supplements; Food supplements and dietetic preparations, namely, dietary supplements; liquid herb-based food supplements; nutraceuticals for therapeutic use for the treatment of gastrointestinal diseases; nutraceutical products for animals, namely, nutraceuticals for use as a dietary supplement; nutraceutical products for humans, namely, nutraceuticals for use as a dietary supplement; nutraceutical products, namely, nutraceuticals used as dietary supplements; nutraceutical preparations for therapeutic or medical use for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases, musculo-skeletal disorders, hyperlipidemia, of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, of damaged skin and tissue; Medical preparations for the treatment of gastrointestinal diseases; medical preparations for slimming; pharmaceutical preparations, namely, elixirs for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; medicated preparations for skin treatments; pharmaceutical substances and preparations with anti-inflammatory properties, namely, anti-inflammatories; plant preparations for medical use, namely, plant extracts for medical purposes; pharmaceutical preparations for immune system regulation; feed supplements for livestock for veterinary use; nutritional additives for animal feed for use as nutritional supplements for medical purposes; food supplements for animals; dietary supplements for pets; plant and herb extracts for medicinal use; medicinal plant extracts; plant extracts for pharmaceutical use; dietetic substances for medical use, namely, dietary supplements; pharmaceutical products, namely, pharmaceutical preparations for gastrointestinal diseases; plant extracts for medical use; food supplements for non-medical use; medicated food supplementsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 17, 2026C71TCANCELLED SECTION 71—
Oct 1, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 20, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 14, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 25, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 25, 2020FIMPFINAL DISPOSITION PROCESSED—
Jan 1, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 1, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 16, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jun 12, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 12, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 12, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 10, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2019ALIEASSIGNED TO LIE—
May 31, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2019RFNTREFUSAL PROCESSED BY IB—
Dec 29, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 29, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 12, 2018DOCKASSIGNED TO EXAMINER—
Nov 3, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 30, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 25, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance